FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE) has reported earnings 22 times since May 05, 2021. The stock moves an average of ±5.90% the day after reporting, closing higher 36.4% of the time. Its largest post-earnings gain was +20.21% (Aug 12, 2025) and its largest decline was -11.4% (May 04, 2022). The next earnings report is predicted for 2026-11-12 (approximate).
Earnings reactions
How FATE moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±5.90%
Positive %
36.4%
Negative %
63.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 13, 2026 | ☀ PRE | -7.54% | open_in_new |
| May 13, 2026 | ☀ PRE | -5.12% | open_in_new |
| Feb 26, 2026 | ☀ PRE | +5.41% | open_in_new |
| Nov 13, 2025 | ☀ PRE | -4.81% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±5.90%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260813 | open_in_new SEC.gov |
| S-8 | 20260813 | open_in_new SEC.gov |
| 4 | 20260805 | open_in_new SEC.gov |
| 4 | 20260805 | open_in_new SEC.gov |
| 144 | 20260804 | open_in_new SEC.gov |
| 144 | 20260804 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260708 | open_in_new SEC.gov |
| 3 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
Frequently asked about FATE earnings
When does FATE THERAPEUTICS INC report earnings next? expand_more
FATE THERAPEUTICS INC (FATE)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does FATE stock move after earnings? expand_more
Over 22 reports, FATE has moved an average of ±5.90% the session after earnings, closing higher 36.4% of the time.
What was FATE's biggest post-earnings move? expand_more
FATE's largest post-earnings gain on record was +20.21% on Aug 12, 2025, and its largest decline was -11.4% on May 04, 2022.
Where can I find FATE THERAPEUTICS INC's SEC filings? expand_more
All of FATE THERAPEUTICS INC's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right